Log In

Earlier Steroid Use with Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed/Refractory Large B Cell Lymphoma (R/R LBCL)

Files

How and where to find an Open Access version of this publication?

Publication date

2020-03

Authors

Topp, Max S.
van Meerten, Tom
Houot, Roch
Minnema, Monique C.ORCID 0000-0002-3139-8379ISNI 0000000394782842
Milpied, Noel
Lugtenburg, Pieternella J.
Thieblemont, Catherine
Wermke, Martin
Song, Kevin
Avivi, Irit

Editors

Advisors

Supervisors

DOI

https://doi.org/10.1016/j.bbmt.2019.12.603

Document Type

Abstract

Metadata

Show full item record

Collections

UMC Repository

License

Abstract

Keywords

Citation

Topp, M S, van Meerten, T, Houot, R, Minnema, M, Milpied, N, Lugtenburg, P J, Thieblemont, C, Wermke, M, Song, K, Avivi, I, Kuruvilla, J, Duehrsen, U, Chu, R, Zheng, L, Plaks, V, Kerber, A & Kersten, M J 2020, 'Earlier Steroid Use with Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed/Refractory Large B Cell Lymphoma (R/R LBCL)', Biology of Blood and Marrow Transplantation, vol. 26, no. 3, pp. S101-S101. https://doi.org/10.1016/j.bbmt.2019.12.603

URI

https://dspace.library.uu.nl/handle/1874/394926